Minimally invasive local therapies for liver cancer

Primary and metastatic liver tumors are an increasing global health problem, with hepatocellular carcinoma (HCC) now being the third leading cause of cancer-related mortality worldwide. Systemic treatment options for HCC remain limited, with Sorafenib as the only prospectively validated agent shown...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, David, Kang, Josephine, Golas, Benjamin J., Yeung, Vincent W., Madoff, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296086/
https://www.ncbi.nlm.nih.gov/pubmed/25610708
http://dx.doi.org/10.7497/j.issn.2095-3941.2014.04.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296086/
https://www.ncbi.nlm.nih.gov/pubmed/25610708
http://dx.doi.org/10.7497/j.issn.2095-3941.2014.04.001

Ejemplares similares